ESC 365 - Cost-effectiveness of the CNIC-polypill strategy for the secondary prevention of CV disease in male and female patients with established coronary heart disease based on improved risk factor control

ESC Premium Access

Cost-effectiveness of the CNIC-polypill strategy for the secondary prevention of CV disease in male and female patients with established coronary heart disease based on improved risk factor control

Session: Risk Factors and Prevention ePosters

Topic: Secondary Prevention

Speaker: Doctor C. Aguiar (Lisbon, PT)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Carlos Aguiar

Hospital Santa Cruz, Lisbon (Portugal)

11 presentations

5 followers

224 more presentations in this session

High risk characteristics in patients with hypertrophic cardiomiyopathy for predicting cardiovascular events

Speaker: Doctor B. Keskin (Istanbul, TR)

Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines

Speaker: Doctor R. Ong (Makati, PH)

Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndromes; final data of the nationwide cross-sectional CardioRisk project

Speaker: Doctor A. Bendary (Benha, EG)

SF-12 Physical and Mental Health Scales predict cardiovascular events after hospitalization

Speaker: Mr R. Gascuena (Leganes, ES)

Comparison of traditional versus artificial intelligence based coronary artery disease risk prediction scores in young patients with acute coronary syndrome

Speaker: Doctor S. Vohra (Lucknow, IN)

Access the full session

Risk Factors and Prevention ePosters

Speakers: Doctor C. Aguiar, Doctor B. Keskin, Doctor R. Ong, Doctor A. Bendary, Mr R. Gascuena...

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

Open Access

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice - panel.

30 August 2021

Open Access

Management of ASCVD risk in people with diabetes mellitus.

30 August 2021

Open Access

Introduction, novel concepts in the 2021 ESC Prevention Guideline.

30 August 2021

ESC 365 is supported by